This inventor holds 1 USPTO granted patent. Top assignees: Cyt Immune Sciences, Inc., Virginia Tech Intellectual Properties Inc.. Active years: 2013.
Company Filing History:
1 out of 14 
1 out of 823 
Years Active: 2013
Title: Marja S Hubta: Innovator in Drug Delivery Systems
Introduction
Marja S Hubta is a prominent inventor based in Seattle, Washington. She has made significant contributions to the field of drug delivery systems, particularly through her innovative work involving thiolated paclitaxels.
Latest Patents
Marja holds a patent for "Thiolated paclitaxels for reaction with gold nanoparticles as drug delivery agents." This patent describes how thiolated taxane derivatives can be linked to colloidal metal particles, such as gold nanoparticles, for use as antitumor agents. The targeted delivery of these agents to tumors represents a significant advancement in cancer treatment.
Career Highlights
Throughout her career, Marja has worked with notable organizations, including Virginia Tech Intellectual Properties, Inc. and Cyt Immune Sciences, Inc. Her work has focused on developing innovative solutions that enhance the efficacy of drug delivery systems.
Collaborations
Marja has collaborated with esteemed colleagues, including David G I Kingston and Shugeng Cao. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Marja S Hubta's work in drug delivery systems exemplifies her commitment to innovation in the medical field. Her contributions continue to pave the way for advancements in cancer treatment and drug delivery technologies.